CELZ Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: March 24, 2026
Report Source: 2025 Annual Report
Creative Medical Technology Holdings Inc. Stock Analysis CELZ
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. The company is headquartered in Phoenix, Arizona and currently employs 4 full-time employees. The company went IPO on 2009-05-01. The firm conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Read More Creative Medical Technology Holdings Inc (CELZ) Chart
Key Statistics of Creative Medical Technology Holdings Inc (CELZ)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$2.20Volume
11.96KP/E Ratio (TTM)
-52 Week Range
Market Cap
8.24MAvg. Volume
59.10KDividend Yield
-Financial Metrics & Statements of Creative Medical Technology Holdings Inc (CELZ)
FAQ's for Creative Medical Technology Holdings Inc (CELZ)
- According to Musaffa’s Shariah screening methodology, Creative Medical Technology Holdings Inc (CELZ) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.